j.vandermolen
TL3 Regular · Catania, IT
Clinician. Posts general information only, and says so every time.
Joined 16 July 2024 · last posted 1d · groups: clinicians
124 posts, newest first. Showing up to 150.
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #90 · Start Here › Welcome · 27 Jul 2026 · 1 like Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #75 · Compounds › Retatrutide · 19 Jul 2026 · 1 like Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
-
Why the Start Here categories exist, and what they are not for Replied, post #10 · Start Here › Welcome · 18 Jul 2026 · 3 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
-
Pooling trials with different estimands Replied, post #95 · Evidence › Meta-analyses · 13 Jul 2026 · 0 likes On post #91 — agreed on the reasoning, with one qualification. Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size…
-
Reused chromatograms across lots: how to spot it Replied, post #57 · Analytics › COA interpretation · 13 Jul 2026 · 10 likes Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent water is normal. The difference between a TFA salt and an acetate salt can be…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #76 · Access › International · 13 Jul 2026 · 6 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #58 · Compounds › Repair & healing peptides · 12 Jul 2026 · 3 likes Publication patterns in the BPC-157 literature: a large proportion of the evidence comes from one research group. That is not necessarily wrong — one group can do…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #68 · Analytics › Impurities & related substances · 11 Jul 2026 · 14 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #11 · Access › Insurance & coverage · 9 Jul 2026 · 6 likes Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected…
-
AOD-9604 and the fragment hypothesis, revisited — does this still hold? Replied, post #11 · Compounds › Other compounds · 8 Jul 2026 · 3 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #13 · Practice › Interactions · 5 Jul 2026 · 0 likes Coming back to post #11, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Restarting after a long gap: what the labelling implies Replied, post #12 · Practice › Dosing & titration · 5 Jul 2026 · 0 likes Picking up post #9: that is the part I would want checked first. Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose…
-
Private prescribing in the UK: what is actually involved Replied, post #50 · Regional › UK & Ireland · 28 Jun 2026 · 0 likes Coming back to post #48, because the follow-up matters more than the original answer. Private prescribing is legal and widespread, including through remote…
-
Personal or family history of medullary thyroid carcinoma Replied, post #21 · Safety › Contraindications · 27 Jun 2026 · 13 likes Medullary thyroid carcinoma (personal or family history) or multiple endocrine neoplasia type 2: absolute contraindication. The rodent preclinical signal is real enough…
-
Personal or family history of medullary thyroid carcinoma Replied, post #2 · Safety › Contraindications · 20 Jun 2026 · 7 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
-
An appeal that succeeded, with the letter structure Replied, post #9 · Access › Insurance & coverage · 17 Jun 2026 · 27 likes This follows post #6 rather than contradicting it. Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #40 · Evidence › Journal club · 12 Jun 2026 · 0 likes Picking up post #37: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #13 · Evidence › Trials · 12 Jun 2026 · 0 likes Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #98 · Practice › Reconstitution · 9 Jun 2026 · 0 likes post #97 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Reading a trial's population section before its results Replied, post #99 · Evidence › Trials · 8 Jun 2026 · 18 likes On post #95 — agreed on the reasoning, with one qualification. The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #73 · Practice › Reconstitution · 26 May 2026 · 0 likes I read post #71 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #136 · Compounds › Tirzepatide · 23 May 2026 · 15 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
The anatomy of a question that gets answered within an hour Replied, post #43 · Start Here › How to Ask · 12 May 2026 · 18 likes I read post #41 twice before replying, because I had assumed the opposite. Lab result questions: state the result, the reference interval, and what else is on the same…
-
Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose Replied, post #13 · Practice › Administration · 9 May 2026 · 12 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
A checklist for reading a certificate in under two minutes Replied, post #14 · Analytics › COA interpretation · 2 May 2026 · 1 like On post #10 — agreed on the reasoning, with one qualification. Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #87 · Evidence › Trials · 26 Apr 2026 · 4 likes post #86 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Follow-up: State-level differences that actually matter Replied, post #95 · Regional › North America · 9 Apr 2026 · 8 likes This follows post #92 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
About the UK & Ireland category Replied, post #3 · Regional › UK & Ireland · 7 Apr 2026 · 19 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
The "under review" status pill and when a moderator applies it Replied, post #56 · Evidence › Preprints · 5 Apr 2026 · 22 likes Picking up post #53: that is the part I would want checked first. What changes between preprint and publication: authors respond to reviewer comments, re-analyse data,…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #6 · Analytics › Mass spectrometry · 13 Mar 2026 · 0 likes I read post #4 twice before replying, because I had assumed the opposite. Resolution: "high resolution" commonly means
-
The lowest dose that does anything: is that a real question? Replied, post #88 · Practice › Dosing & titration · 7 Mar 2026 · 3 likes Worth separating two things that post #84 runs together. Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #126 · Practice › Interactions · 6 Mar 2026 · 5 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
About the Storage & stability category Replied, post #3 · Practice › Storage & stability · 2 Mar 2026 · 5 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #135 · Analytics › COA interpretation · 18 Feb 2026 · 15 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
Constipation management, with a dietitian's contribution Replied, post #31 · Practice › Side effects · 18 Feb 2026 · 2 likes Worth separating two things that post #27 runs together. Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and…
-
[2026 update] What a purity-only report leaves out Replied, post #27 · Sourcing › Independent verification · 16 Feb 2026 · 12 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #27 · Practice › Dosing & titration · 16 Feb 2026 · 1 like I read post #25 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #30 · Evidence › Trials · 15 Feb 2026 · 20 likes Picking up post #27: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #88 · Documentation › Wiki requests · 14 Feb 2026 · 12 likes post #87 is right about the mechanism and I think understates the practical bit. Correction requests: if you spot an error in a maintained page, note it here with the…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #22 · Data & Tools › Datasets · 4 Feb 2026 · 7 likes I read post #20 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Second pass at: Submitting a sample: the process end to end Replied, post #6 · Sourcing › Independent verification · 3 Feb 2026 · 3 likes post #5 is right about the mechanism and I think understates the practical bit. Repeat testing: if you want to verify the same lot a second time, testing with a…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #14 · Practice › Administration · 28 Jan 2026 · 0 likes Worth separating two things that post #10 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #118 · Clinical › Special populations · 27 Jan 2026 · 12 likes Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait before attempting pregnancy) are not formally…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #23 · Pharmacology › Pharmacokinetics · 24 Jan 2026 · 0 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
-
A 10 mg vial reconstituted three different ways, compared Started this topic · Practice › Reconstitution · 9 Jan 2026 · 14 likes Posting this under the heading it deserves: A 10 mg vial reconstituted three different ways, compared Everything below is what sits behind that. Practical question with…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #7 · Practice › Administration · 8 Jan 2026 · 0 likes On post #3 — agreed on the reasoning, with one qualification. A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 — does this still hold? Replied, post #13 · Compounds › Cagrilintide & amylin analogues · 23 Dec 2025 · 0 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
-
Heterogeneity as information rather than as a nuisance Replied, post #34 · Evidence › Meta-analyses · 22 Dec 2025 · 6 likes Publication bias: what did not get published? Small studies with negative results are less likely to be published than large studies with positive results. A forest…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #56 · Compounds › Tirzepatide · 8 Dec 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #72 · Analytics › Home & field testing · 7 Dec 2025 · 0 likes What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It…
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #32 · Analytics › Method validation · 27 Nov 2025 · 23 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #10 · Sourcing › Independent verification · 27 Nov 2025 · 0 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #96 · Compounds › Other compounds · 26 Nov 2025 · 25 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #55 · Compounds › Oral incretins · 22 Nov 2025 · 9 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
What a regulator's shortage notice actually authorises — what changed since Replied, post #17 · Sourcing › Regulatory · 8 Nov 2025 · 14 likes post #16 is right about the mechanism and I think understates the practical bit. Approval versus licensing: a compound can be approved for a specific indication in one…
-
Guidelines revision: what changed and why — one year on Replied, post #30 · Meta › Announcements · 29 Oct 2025 · 7 likes Staff-only posts: some announcements are visible only to staff (concerning internal operations). Members see public announcements.
-
Sleep tracking data and its considerable limitations Replied, post #117 · Wellbeing › Sleep · 28 Oct 2025 · 0 likes Coming back to post #115, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #74 · Practice › Reconstitution · 28 Oct 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Deconvolution of a multiply charged envelope Replied, post #3 · Analytics › Mass spectrometry · 30 Sep 2025 · 0 likes Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #133 · Practice › Reconstitution · 26 Sep 2025 · 13 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #59 · Lounge › Off topic · 26 Sep 2025 · 3 likes Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no endorsements of other communities. Just a relaxed bar for how directly the topic needs to…
-
What pooling buys you and what it destroys Replied, post #25 · Evidence › Meta-analyses · 20 Sep 2025 · 23 likes Coming back to post #23, because the follow-up matters more than the original answer. Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion…
-
What this community means by "a source", in practical terms Replied, post #120 · Start Here › Welcome · 19 Sep 2025 · 11 likes The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #144 · Practice › Storage & stability · 18 Sep 2025 · 7 likes Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #138 · Data & Tools › Datasets · 11 Sep 2025 · 2 likes Privacy: if contributing data, only share data you are comfortable making permanent and public. Once posted, data is persistent.
-
Are there stupid questions here? A staff answer, at length Replied, post #150 · Start Here › Welcome · 4 Sep 2025 · 26 likes There is no stupid-questions rule and no penalty for asking badly. The response to a poorly framed question is a request for clarification, not rudeness. That is a…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #63 · Evidence › Journal club · 31 Aug 2025 · 1 like STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #16 · Analytics › Method validation · 26 Aug 2025 · 0 likes Picking up post #13: that is the part I would want checked first. Why two laboratories may disagree: after validating the same method, they may still report different…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #114 · Compounds › Semaglutide · 11 Aug 2025 · 3 likes post #113 answers the question as asked. The question underneath it is different. Approved indications differ by jurisdiction and change. As of mid-2026 the…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #18 · Analytics › Method validation · 11 Aug 2025 · 13 likes This follows post #15 rather than contradicting it. Why two laboratories may disagree: after validating the same method, they may still report different purity on the…
-
When a preprint is the best available evidence and we say so Replied, post #30 · Evidence › Preprints · 6 Aug 2025 · 10 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
-
Micronutrient status when intake falls substantially Replied, post #22 · Clinical › Bloodwork · 5 Aug 2025 · 0 likes Worth separating two things that post #18 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
[2026 update] Comparing documentation quality across the directory, tabulated Started this topic · Sourcing › Vendor reports · 27 Jul 2025 · 7 likes On the subject in the title: Comparing documentation quality across the directory, tabulated Working notes rather than a conclusion. I would like to talk about…
-
What this community means by "a source", in practical terms Replied, post #42 · Start Here › Welcome · 21 Jul 2025 · 5 likes The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
-
Repeatability versus intermediate precision Replied, post #63 · Analytics › Method validation · 25 Jun 2025 · 0 likes Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #89 · Nutrition & Training › Protein & intake · 14 Jun 2025 · 20 likes Coming back to post #87, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Coming back to: Getting a referral rather than a refusal Replied, post #56 · Clinical › Prescriber conversations · 11 Jun 2025 · 0 likes This follows post #53 rather than contradicting it. Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring…
-
Sodium, potassium and magnesium when intake drops Replied, post #12 · Nutrition & Training › Hydration & electrolytes · 11 Jun 2025 · 5 likes Sodium: losing weight involves losing some sodium. Electrolyte drinks or salty foods help maintain sodium balance. Very low sodium intake on these compounds raises…
-
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #2 · Start Here › Welcome · 10 Jun 2025 · 8 likes Picking up the opening post: that is the part I would want checked first. Marked solutions are the site's way of saying that someone asked a good question and someone…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #42 · Nutrition & Training › Protein & intake · 1 Jun 2025 · 10 likes Coming back to post #40, because the follow-up matters more than the original answer. Timing of protein: spreading protein intake across the day, with some at each…
-
A report I filed that turned out to be wrong, and the correction Replied, post #76 · Sourcing › Vendor reports · 29 May 2025 · 0 likes Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from one. Our vendor pages deliberately mix services for that…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #94 · Outcomes › Body composition · 25 May 2025 · 8 likes Picking up post #91: that is the part I would want checked first. Changes during titration: measuring body composition during active titration is less useful than…
-
Relative retention time as a better inter-laboratory comparator Replied, post #11 · Analytics › Method validation · 19 May 2025 · 5 likes Worth separating two things that post #7 runs together. Specificity: the method can distinguish the intended compound from related impurities and degradation products.…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #48 · Outcomes › Body composition · 16 May 2025 · 14 likes Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is maintained, metabolic rate is usually maintained better than…
-
Fibre intake when total intake falls, and the constipation link Replied, post #66 · Nutrition & Training › Protein & intake · 11 May 2025 · 0 likes Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain lean mass is the priority. Protein comes second to total intake.
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #90 · Evidence › Journal club · 21 Apr 2025 · 4 likes Coming back to post #88, because the follow-up matters more than the original answer. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and…
-
Counter-ion content and its effect on measured mass Replied, post #16 · Analytics › Mass spectrometry · 12 Apr 2025 · 2 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
-
Retatrutide dose escalation in the published trials Replied, post #95 · Compounds › Retatrutide · 6 Apr 2025 · 0 likes Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
-
A well-designed study with a badly written abstract Replied, post #9 · Evidence › Study critique · 4 Apr 2025 · 5 likes post #8 is right about the mechanism and I think understates the practical bit. Criticise the method, not the author: a paper with a weak design is not a bad paper by…
-
Sequence verification for an obscure compound: how it is done Replied, post #4 · Compounds › Other compounds · 31 Mar 2025 · 9 likes Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds that are genuinely novel and difficult to obtain…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #40 · Practice › Reconstitution · 29 Mar 2025 · 13 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #127 · Analytics › COA interpretation · 26 Mar 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Validating a method you did not develop — does this still hold? Replied, post #147 · Analytics › Method validation · 21 Mar 2025 · 20 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #8 · marked as the solution · Practice › Storage & stability · 20 Mar 2025 · 7 likes post #7 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #36 · Sourcing › Vendor reports · 16 Mar 2025 · 28 likes Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial.
-
Bleeding at the injection site: normal, and what to do about it — does this still hold? Replied, post #11 · Practice › Administration · 14 Mar 2025 · 0 likes Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the stinging sensation substantially. This is the simplest thing to try…
-
State-level differences that actually matter Replied, post #2 · Regional › North America · 10 Mar 2025 · 4 likes Compounding pharmacies: pharmaceutical compounding of a drug not on the FDA shortage list is substantially constrained. The landscape changed when supply normalised.…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #25 · Practice › Reconstitution · 3 Mar 2025 · 15 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #12 · Compounds › Cagrilintide & amylin analogues · 21 Feb 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #2 · Devices › Syringes & needles · 19 Feb 2025 · 24 likes Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the plunger to check for blood) is not necessary and is sometimes discouraged…
-
Follow-up: Attributing a new peak: degradation product or excipient? Replied, post #7 · Analytics › Impurities & related substances · 15 Feb 2025 · 7 likes Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #15 · Compounds › Retatrutide · 15 Feb 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Consistent declarations and why they matter more than clever ones Replied, post #23 · Sourcing › Logistics · 12 Feb 2025 · 0 likes Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling problem in transit. The contents may or may not be…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #9 · Compounds › Semaglutide · 11 Feb 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
What a 2 ppm match establishes, and what it does not Started this topic · Analytics › Mass spectrometry · 10 Feb 2025 · 2 likes What a 2 ppm match establishes, and what it does not — that is the question, and I have not found it answered plainly anywhere I have looked. Working through the…
-
Scheduled maintenance and what will be unavailable Replied, post #26 · Meta › Announcements · 27 Jan 2025 · 11 likes Staff-only posts: some announcements are visible only to staff (concerning internal operations). Members see public announcements.
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #2 · Evidence › Meta-analyses · 24 Jan 2025 · 4 likes Coming back to the opening post, because the follow-up matters more than the original answer. Fixed-effects versus random-effects models: fixed-effects assumes all…
-
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #19 · Sourcing › Vendor reports · 3 Jan 2025 · 0 likes Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently, that is information. If they have been consistent over years, that…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #73 · Compounds › Semaglutide · 2 Jan 2025 · 2 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
Coming back to: When to suspect the method rather than the sample Replied, post #95 · Analytics › Method validation · 18 Dec 2024 · 23 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
-
Oxidation and deamidation mass shifts, tabulated Replied, post #20 · Analytics › Mass spectrometry · 15 Dec 2024 · 10 likes Picking up post #17: that is the part I would want checked first. Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057,…
-
Coming back to: When to suspect the method rather than the sample Replied, post #76 · Analytics › Method validation · 15 Dec 2024 · 7 likes I read post #74 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Body image changing more slowly than the body Replied, post #28 · Wellbeing › Mental health · 13 Dec 2024 · 0 likes post #27 answers the question as asked. The question underneath it is different. Identity and self-image: for some people, weight and body size are central to identity.…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #21 · Devices › Cold chain · 13 Dec 2024 · 6 likes Shipment during summer or to hot climates: consider shipping to a cold-storage facility rather than to home if temperatures will be high. Alternatively, time shipment…
-
Why "any advice?" is the least effective ending for a post Replied, post #68 · Start Here › How to Ask · 24 Nov 2024 · 31 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
-
EMA product information as a primary source — does this still hold? Replied, post #142 · Regional › European Union · 18 Nov 2024 · 0 likes EMA is the regulator with national implementation. Licensed incretin analogues are prescription-only across the EU, with some variation in specific approvals by member…
-
Oxidation and deamidation mass shifts, tabulated Replied, post #2 · Analytics › Mass spectrometry · 31 Oct 2024 · 13 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #107 · Sourcing › Independent verification · 4 Oct 2024 · 12 likes Coming back to post #105, because the follow-up matters more than the original answer. Janoshik Analytical: chromatographic purity and mass-spectrometric identity on…
-
US compounding rules and how they changed Replied, post #2 · Regional › North America · 25 Sep 2024 · 1 like Picking up the opening post: that is the part I would want checked first. Prior authorisation, step therapy, and exclusion of weight-management indications from…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #36 · Practice › Administration · 17 Sep 2024 · 0 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #19 · Compounds › Retatrutide · 5 Sep 2024 · 15 likes Coming back to post #17, because the follow-up matters more than the original answer. Glucagon receptor agonism seems paradoxical in a weight-loss compound because…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #32 · Evidence › Journal club · 2 Sep 2024 · 0 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #27 · Compounds › Semaglutide · 29 Aug 2024 · 3 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Circumference measurements as a poor man's composition estimate Replied, post #63 · Outcomes › Body composition · 13 Aug 2024 · 0 likes post #62 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…